CN108060227A - A kind of amplimer, kit and its detection method for detecting PAH gene mutations - Google Patents
A kind of amplimer, kit and its detection method for detecting PAH gene mutations Download PDFInfo
- Publication number
- CN108060227A CN108060227A CN201810154162.9A CN201810154162A CN108060227A CN 108060227 A CN108060227 A CN 108060227A CN 201810154162 A CN201810154162 A CN 201810154162A CN 108060227 A CN108060227 A CN 108060227A
- Authority
- CN
- China
- Prior art keywords
- primer
- pcr
- seq
- pah
- sequencing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of amplimer, kit and its detection methods for detecting PAH gene mutations, and for the primer sets of PCR specific amplifications detection PAH gene mutations, totally 9 pairs of this group of PCR primer is as follows respectively:For expanding 1 upstream outer sequence of PAH gene extrons(Positioned at gene 5 ' end)To the primer of introne 2, forward primer such as SEQ ID NO:Shown in 1, reverse primer such as SEQ ID NO:Shown in 2;For expanding 2 upstream of PAH gene introns(5 ' ends)To 2 downstream of introne(3 ' ends)Primer, forward primer such as SEQ ID NO:Shown in 3, reverse primer such as SEQ ID NO:Shown in 4 etc..The present invention realizes PAH gene all standings, the sequence length detected reaches 88171bp, contribute to variation and the detection of structure variation in introne, the recall rate of pathogenic mutation can be improved, and operation is more simple, at low cost, in addition each amplified fragments have overlay region with adjacent segment, available for fragment assembly and haplotype reconstruction.
Description
Technical field
The present invention relates to PAH gene technology field, more particularly to a kind of amplimer, reagent for detecting PAH gene mutations
Box and its detection method.
Background technology
Phenylalanine hydroxylase deficiency(phenylalanine hydroxylase deficiency,PAHD)It is common
Aminoacidopathy, the morbidity of PAHD is due to phenylalanine hydroxylase(phenylalanine hydroxylase,PAH)
Mutation causes enzymatic activity to reduce or lose, and makes phenylalanine metabolic disorder.The PAHD infants of untreated are due to internal excess
The neurotoxic effect of phenylalanine and bypass metabolite can cause serious dysnoesia and symptomatic epilepsy.If it can obtain
To early diagnosis and therapy, then neurotrosis can not then occur, normal intelligence.With the development of clinical diagnosis and treatment, PAHD has become
It can treat, preventible disease.Since infant not occurring symptom, PAH gene mutation analysis is in early days the diagnosis method of PAHD.
Meanwhile PAH genetic tests are carried out to patient and also contribute to its lineal relative's genetic counselling, and provided to give birth to antenatal detection again
Foundation.PAH genes are located at human chromosome position 12q23.2, overall length about 90kb, and containing 13 extrons, coding section length is
1359bp encodes the polypeptide chain of 452 amino acid and further folds composition phenylalanine hydroxylase albumen.It reports at present
PAH gene mutation species is more, most of for missense mutation there are about more than 800 kinds, remaining further include shearing mutation, nonsense mutation and
Small missing/insertion mutation, is related to whole gene, has high genetic heterogeneous, there is significant area and racial difference.Together
When, domestic and foreign scholars have been reported that PAH gene mutations part has the large fragment deletion or again across extron and/or introne
Multiple mutation.It at present can clear and definite 90% or so using the method for PCR amplification extron and flank finite region sequence combination DNA sequencing
Patient, the patient for still having 10% or so cannot specify the cause of disease, therefore there is an urgent need for be capable of the detection of specific detection PAH full-length genes
Method.- Sanger nucleotide sequencing methods are cloned using segment detect mankind's PAH genes from DiLella in 1986 et al.
After first pathogenic mutation, occur abrupt climatic change of more and more molecular detection technologies for PAH genes both at home and abroad.It has reported
Gene tester have the hybridization of polymerase chain reaction-allele specific oligonucleotide chain(Polymerase chain
reaction--allele specific oligonucleotides, PCR-ASO), polymerase chain reaction-denaturant gel ladder
Spend electrophoresis(PCR-denaturing gradient gel electrophoresis,PCR-DGGE), polymerase chain reaction-mono-
Chain conformation polymorphism(PCR-Single strand conformation polymorphism,PCR-SSCP), polymerase chain it is anti-
Should-restriction fragment length polymorphism(PCR-restriction fragment length polymorphism, PCR-
RFLP), polymerase chain reaction-denaturing high-performance chromatography(PCR-denaturing high-performance liquid
chromatography, PCR-DHPLC), polymerase chain reaction-high-resolution melting curve analysis(PCR-high
resolution melting,PCR-HRM)Deng having the features such as easy to operate economic and practical, but the drawback is that being only capable of detection has
The specific mutation type of limit or the specific location and type that can not be clearly mutated.At present, Sanger sequencing approaches be clinical practice in
The main method of PAH detection in Gene Mutation.Zhang Zhi in 2006 etc.(The mutation inspection of Classic PKU full length gene extron
It surveys and analyzes,《Chinese eugenic and Journal of Heredity》, 2006, the 5th phase of volume 14,14-16 pages)It establishes to PAH gene extrons
The method of sub- pcr amplification product Sanger sequencings.2007 Nian Song Fang etc.(Northern Part of China Phenylalanine Hydroxylase Gene is dashed forward
Become and form,《Chinese Journal of Medical Genetics》, 2007, the 3rd phase of volume 24,241-246 pages)Point established using Zhang Zhi et al.
Analysis method has carried out Sanger surveys to 230 PKU patients gene whole extrons and its flanking intron sequence
Sequence detects.
For PAH detection in Gene Mutation, have multinomial patent and disclose report.CN1335408A(2002)It discloses suitable
In early diagnosis and the PAH gene mutation DNA chip dedicated for diagnosing of Prenatal Screening phenylketonuria, but this method is only to 40 kinds
PAH gene mutations are detected.CN1696308A(2005)Also disclose and be suitable for early diagnosis and Prenatal Screening propiophenone
The PAH gene mutation DNA chip dedicated for diagnosing of disease is urinated, but this method is only detected 6 kinds of PAH gene mutations.
CN101481741A(2009)Disclose the exon of the 4th, 5,6,7,10,11 and 12 using specific amplification PAH genes
And its PCR primer of flanking intron sequence, detect 13 kinds of PAH in conjunction with the methods of Sanger PCR sequencing PCRs, enzymatic mispairing cutting
Gene mutation.CN101570787A(2009)Also a kind of compound chip for antenatal quick diagnosis, but this method are disclosed
Only 5 kinds of PAH gene mutations are detected.CN101899518A(2010)Disclose a kind of detection phenylketonuria PAH bases
Because of the kit and its PCR amplification method of 7 hot mutant sites, because the specificity of its product is very high, can directly observe solidifying
The presence or absence of product band of gel electrophoresis judges the genotype in the corresponding mutational site of PAH genes.CN101693921A(2010)
One kind is disclosed for buccal swab DNA, using specific PCR amplification PAH genes the 7th and the 12nd exon, then is passed through
Sanger sequencing technologies detect the catastrophe of the two extrons.CN201376967Y(2010)It discloses for antenatal fast
The compound chip of speed diagnosis, but this method is only detected 5 kinds of PAH gene mutations.CN102533992A(2012)It announces
A kind of method that Phenylalanine Hydroxylase Gene is sequenced, i.e., simultaneously to the mesh of the 1st to 13 exon of PAH genes
It marks region and carries out specific PCR amplification, PCR product is used to build sequencing library, then carries out high-flux sequence.
CN202671546U(2013)A kind of phenylketonuria Disease-causing gene mutation detection kit is disclosed, that is, utilizes specificity
PCR primer expands 13 extrons of PAH genes, reuses Sanger sequencings and carries out mutation analysis.CN103436616A(2013
Year)Kit that is a kind of while detecting Chinese population phenylketonuria PAH 12 mutantional hotspots of gene is disclosed, is suitable for group
Property examination.CN104031990A(2014)A kind of phenylketonuria PAH gene detecting kits are disclosed, predominantly detect PAH
13 common mutations sites of gene.CN103509865A(2014)It discloses a kind of utilization high-resolution fusion curve and analyzes skill
The sequence of the method that art detects PAH gene mutations, main detectable PAH genes the 3rd, 6,7,11 and 12 exons whether there is
It is abnormal, but specific genotype can not be detected.CN104232770A(2014)Disclose a kind of phenylketonuria genetic test
Kit, the kit quickly detect the genotype in 7 sites of PAH genes using multiple connecting detection reaction technology.
CN105177160A(2015)Disclose a kind of primer for detecting a variety of newborn's Inherited Metabolic Disorders Disease-causing gene mutation and examination
Agent box, 40 Disease-causing genes related to 22 kinds of common newborn's Inherited Metabolic Disorders(Include PAH genes)Extron and extron
The sequence of introne calmodulin binding domain CaM carries out specific primer multiplex PCR, then carries out the sequencing of two generations and analysis, provides detection gene
Abrupt information.CN105755109A(2016)Disclose a kind of new phenylketonuria gene screening and diagnosis system and reagent
Box, using the system constructed by round pcr, DNA interconnection techniques and capillary electrophoresis technique, the PAH gene more typical to 41
Mutational site is detected.PAH gene extrons total length is 4122bp(Reference gene group is GRCh37/hg19), and include
Sub- total length is but up to 76597bp(Reference gene group is GRCh37/hg19), above-mentioned report technology is just for mutational site progress
Detection or detection PAH gene extrons subsequence and small part are located at the intron sequences of extron flank, and cannot be directed to PAH
Gene whole intron sequences are detected, and this field stills need a kind of gene tester that can detect PAH full length genes,
I.e. this method can not only detect whole exon sequences, moreover it is possible to the whole intron sequences of detection.
In past 10 years, sequencing technologies have developed rapidly, and the sequencing of Illumina both-ends and Ion Torrent half occurs
Conductor sequencing is the second generation sequencing technologies represented and the third generation sequencing technologies as representative is sequenced with PacBio SMRT.
The sequencing of Illumina both-ends is fast and accurately sequenced using fasciation into the method being sequenced in synthesis to realize.This process
It is identified while DNA base is added in nucleic acid chains.Each base is sent while the chain constantly extended is added in
Unique fluorescence signal, these signals can be used to determine the order of DNA sequence dna.The sequencing of Ion Torrent semiconductors is base
In the revolutionary sequencing technologies of a new generation of semiconductor chip, which has used a kind of high-density semiconductor core for being covered with aperture
Piece, an aperture are exactly a sequencing reaction pond.When archaeal dna polymerase is a kind of DNA chain being aggregated in extension in 4 kinds of dNTP
When upper, a hydrogen ion can be discharged, the pH value in reaction tank can change, and the ion receptor under pond experiences this letter
Number, chemical signal is converted into digital signal, so as to read DNA sequence dna.PacBio SMRT sequencings are also based on side synthesis
The principle of side sequencing, the core of this technology are to have used zero level guide technology(Zero-Mode Waveguide, ZMW), often
A ZMW fixes an archaeal dna polymerase and a DNA profiling, is fluorescently labeled the nucleotide of phosphoric acid group in polymerase activity position
It is combined on point with template strand(Each deoxynucleotide is by the dye marker without color), fluorescence is inspired, in fluorescent pulse
After, labeled phosphoric acid group is cut and discharges.Polymerase is transferred to next position, and next deoxynucleotide connects
It is connected on site and starts to discharge fluorescent pulse, carry out next cycling, realize sequencing.The characteristics of PacBio SMRT are sequenced has reading
Long overlength, the features such as GC skewed popularities are small, accuracy is high, it can directly dock long-chain PCR(long-range PCR,LR-PCR)Production
Object is sequenced, without fragmentation processing and PCR amplification again.Due to PAH gene whole extrons and whole intrones
It is added together total length 80719bp(Reference gene group is GRCh37/hg19), traditional Sanger, which is sequenced, will complete the full length gene
Sequence, workload is very big, and expense is high, and uses high throughput sequencing technologies that can be carried out simultaneously to PAH full length genes
Sequencing can shorten detection cycle, reduce workload and testing cost.
Therefore, a kind of amplimer, kit and its detection method for detecting PAH gene mutations is invented to solve above-mentioned ask
It inscribes necessary.
The content of the invention
It is an object of the invention to provide it is a kind of detect PAH gene mutations amplimer, kit and its detection method,
To solve the problems mentioned in the above background technology.
To achieve the above object, the present invention provides following technical solution:A kind of amplimer for detecting PAH gene mutations,
Kit and its detection method, for PCR specific amplifications detection PAH gene mutations primer sets, totally 9 pairs of this group of PCR primer,
It is as follows respectively:
For expanding 1 upstream outer sequence of PAH gene extrons(Positioned at gene 5 ' end)To the primer of introne 2, forward direction is drawn
Object such as SEQ ID NO:Shown in 1, reverse primer such as SEQ ID NO:Shown in 2;
For expanding 2 upstream of PAH gene introns(5 ' ends)To 2 downstream of introne(3 ' ends)Primer, forward primer such as SEQ
ID NO:Shown in 3, reverse primer such as SEQ ID NO:Shown in 4;
For expanding the primer that PAH gene introns 2 arrive introne 3, forward primer such as SEQ ID NO:Shown in 5, reversely draw
Object such as SEQ ID NO:Shown in 6;
For expanding 3 upstream of PAH gene introns(Introne 5 ' is held)To introne 3 downstream(Introne 3 ' end)Primer,
Forward primer such as SEQ ID NO:Shown in 7, reverse primer such as SEQ ID NO:Shown in 8;
For expanding the primer that PAH gene introns 3 arrive introne 4, forward primer such as SEQ ID NO:Shown in 9, reversely draw
Object such as SEQ ID NO:Shown in 10;
For expanding the primer that PAH gene introns 4 arrive introne 5, forward primer such as SEQ ID NO:Shown in 11, reversely draw
Object such as SEQ ID NO:Shown in 12;
For expanding the primer that PAH gene introns 5 arrive introne 7, forward primer such as SEQ ID NO:Shown in 13, reversely draw
Object such as SEQ ID NO:Shown in 14;
For expanding the primer that PAH gene introns 5 arrive introne 11, forward primer such as SEQ ID NO:Shown in 15, reversely
Primer such as SEQ ID NO:Shown in 16;
For expanding PAH gene introns 9 to sequence on the outside of 3 downstream of exons 1(It is held positioned at gene 3 ')Primer, forward direction draws
Object such as SEQ ID NO:Shown in 17, reverse primer such as SEQ ID NO:Shown in 18.
For the kit of PCR specific amplifications detection PAH gene mutations, draw comprising one or more pairs of in primer sets
Object.
Preferably, the kit for the detection PAH gene mutations of PCR specific amplifications is also comprising one or more examinations
Agent carries out the long-chain PCR " reagents of long-range PCR, LR-PCR " reactions using the primer;It is carried out using the primer
Reagent D NA polymerases, buffer solution and the dNTP mixtures of Long fragment PCR reaction;For handling amplified production so that amplification production
Object can be used for the reagent in high throughput sequencing technologies.
Preferably, the kit includes following reagents, one or more pairs of primers, 10 × GeneAmp in PCR primer group
High Fidelity PCR buffer solutions, 10mmol/LdNTP, 5mol/L glycine betaine, DMSO and 5U/ μ L polymerase mixtures.
Preferably, following components are contained in the PCR reaction systems for being 50 μ l in total volume:Each 1 μ l of each PCR primer, draw
The concentration of object is 10 μm of ol/L;10 × GeneAmp High Fidelity PCR buffer solutions 5 μ l, 10mmol/L, dNTP2 μ l, 10
μm each 5 μ l, DMSO2.5 μ l, 5U/ μ l polymerase mixtures of 1 μ l, 5mol/L glycine betaine, 1 μ l, 50ng/ μ l of the forward and reverse primers of ol/L
2 μ l of genomic DNA, 30.5 μ l of water.
A kind of amplimer, kit and its detection method for detecting PAH gene mutations, comprises the following steps:
(1)Using human gene group DNA as template, the primer sets of usage right requirement 1, in the condition suitable for amplification purpose nucleic acid
Under, PAH genes are expanded using LR-PCR technologies, wherein being made of per pair of primers forward primer and reverse primer.
(2)To 9 long segment products of amplification, purifying recycling is carried out;
(3)9 PCR products of purifying are mixed, and are quantified, obtain the PCR product of 1 people's genome DNA sample
Library;
(4)DNA fragmentation processing is carried out to obtaining PCR product library;Wherein described DNA fragmentation method includes the chemistry side of interrupting
Method and physics interrupt method, wherein the chemical method includes swivel base enzyme process and traditional enzymatic cleavage methods, the physical method includes
Ultrasound interrupts method or machinery interrupts method, and the PCR product library interrupted is built 1 sequencing text using splice tag technology
Storehouse, can be respective to distinguish by adding different library connector Barcode Adapter to different genome DNA samples
Sequencing library also can handle PCR product library without fragmentation, directly build single SMRTBell libraries;
(5)Obtained multiple sequencing libraries are mixed, it is different to be sequenced type according to library, select different microarray datasets into
Row sequencing is read long sequencing etc. including the sequencing of Illumina both-ends, the sequencing of Ion Torrent semiconductors and PacBio SMRT long, is obtained
Obtain the sequencing data in PCR product library;
(6)Different genome DNA sample is distinguished based on label B arcode sequences, by bioinformatic analysis by single sample
The DNA sequencing fragment that product sequencing obtains is compared onto reference PAH genes, is carried out SNVs and Indels extractions, and is carried out structural
The analysis of variation excludes the PAH gene mutation information that polymorphic variation obtains the DNA sample.
Preferably, PAH genes are chosen and design 9 pairs of PCR primers, using LR-PCR as template using human gene group DNA
Technology expands PAH genes, and the region of amplification includes PAH gene whole extrons and whole intron sequences and part
Sequence on the outside of 3 downstream of exons 1 upstream outer sequence and exons 1, exons 1 upstream outer sequence are located at gene 5 ' end, outside
Sequence is located at the end of gene 3 ' on the outside of 13 downstreams of aobvious son, and in addition each amplified fragments have overlay region with adjacent amplified fragments, can use
In fragment assembly and haplotype reconstruction, and available for big structure variation is detected, refer mainly to deletion mutant and gene weight
Multiple mutation;
To 9 long segment products of amplification, purifying recycling is carried out, 9 PCR products of purifying are mixed, and is quantified,
1 PCR product library by inspection DNA sample is obtained, corresponding 1 by inspection genome DNA sample;
To obtained PCR product library construction sequencing library, partly led including Illumina both-ends sequencing library, Ion Torrent
Body sequencing library and SMRTBell libraries, are sequenced in corresponding microarray dataset, after obtaining sequencing data, carry out biological letter
Credit analysis is ceased, obtains PAH full length genes variation information.
The technique effect and advantage of the present invention:The present invention goes out 9 couples of PCR using the sequence information specific designs of PAH genes
Primer, for expanding fragment length in 11846bp between 12890bp, the average length 12481bp of 9 amplified fragments, is to be more than
The long segment of 11kb, common PCR reaction systems and condition are difficult success, and in the SSR-PCR optimization and item of the present invention
Under part, it can be expanded using 9 PCR reactions and obtain PAH gene whole exon sequences and all intron sequences, with other mesh
Mark areas captured technology is compared(Such as chip capture technique and Ampliseq technologies), this method can realize PAH gene all standings, institute
The sequence length of detection reaches 88171bp, contributes to variation and the detection of structure variation in introne, can improve the inspection of pathogenic mutation
Extracting rate, and operation is more simple, and at low cost, in addition each amplified fragments have overlay region with adjacent segment, available for segment
Splicing and haplotype reconstruction.
The present invention realizes PAH gene long-chain PCR amplifications for the first time and the sequencing of Illumina both-ends is used in combination, and for the first time
The sequencing of PAH full length genes is applied in phenylalanine hydroxylase deficiency genetic test research, the present invention is by devising one
The simplified primer of group, the targeting amplification of PAH gene complete sequences is realized based on LR-PCR technologies, and the PCR product of amplification directly turns
One step of seat enzyme process completes DNA fragmentation, end is repaired and connector coupled reaction step, is significantly reduced compared with chip capture technique
The demand of starting DNA, enormously simplifies experimental implementation, shortens the sequencing library structure time, is phenylalanine hydroxylase
Deficiency disease genetic test provides new technical method.
Description of the drawings
Fig. 1 is gene long-chain PCR(LR-PCR)Amplification schematic diagram.
Fig. 2 is the schematic diagram of the 2200 TapeStation System analysis results of Agilent of sequencing library.
Fig. 3 is the overburden depth and coverage rate figure of PAH gene Illumina MiSeq sequencings.
Fig. 4 is the IGV views of two PAH pathogenic mutations in Illumina MiSeq sequencing results.
Specific embodiment
Below in conjunction with the attached drawing in the embodiment of the present invention, the technical solution in the embodiment of the present invention is carried out clear, complete
Site preparation describes, it is clear that described embodiment is only part of the embodiment of the present invention, instead of all the embodiments.It is based on
Embodiment in the present invention, those of ordinary skill in the art are obtained every other without making creative work
Embodiment belongs to the scope of protection of the invention.
The present invention relates to a kind of detection PAH gene mutation methods, the method designs 9 using the sequence information of PAH genes
To PCR primer, using long-chain PCR(long-range PCR,LR-PCR)Technology targeting expands entire PAH genes, covers overall length
Spend the genome sequence for 88171bp, i.e. sequence between 12 genomic locations 103227356 to 103315526 of chromosome(Ginseng
Genome is examined as GRCh37/hg19), which includes PAH gene whole exon sequences(Total length is 4122bp)And whole
Intron sequences(Total length 76597bp), in addition each amplified fragments and adjacent segment have overlay region, available for fragment assembly
And haplotype reconstruction, storehouse is built after amplified production fragmentation, using Illumina gene sequencers or Ion Torrent semiconductors
Sequenator directly builds single SMRTBell libraries after carrying out high-flux sequence or amplified production purifying, mixing, using PacBio
RSII sequenators are sequenced, and sequencing data obtains PAH gene mutation information by bioinformatic analysis.
The present invention provides a kind of primer sets for specific PCR amplification PAH genes, preferred PCR primer such as 1 institutes of table
Show, totally 9 pairs of the PCR primer group, adjacent amplified fragments overlapping areas about 3kb or so, 9 pairs of primer difference of the group are as follows:With
In amplification 1 upstream outer sequence of PAH gene extrons(Positioned at gene 5 ' end)To the primer of introne 2, forward primer such as SEQ
ID NO:Shown in 1, reverse primer such as SEQ ID NO:Shown in 2;For expanding 2 upstream of PAH gene introns(5 ' ends)To including
Sub 2 downstreams(3 ' ends)Primer, forward primer such as SEQ ID NO:Shown in 3, reverse primer such as SEQ ID NO:Shown in 4;For
Expand the primer that PAH gene introns 2 arrive introne 3, forward primer such as SEQ ID NO:Shown in 5, reverse primer such as SEQ ID
NO:Shown in 6;For expanding 3 upstream of PAH gene introns(Introne 5 ' is held)To introne 3 downstream(Introne 3 ' end)Draw
Object, forward primer such as SEQ ID NO:Shown in 7, reverse primer such as SEQ ID NO:Shown in 8;For expanding PAH gene introns 3
To the primer of introne 4, forward primer such as SEQ ID NO:Shown in 9, reverse primer such as SEQ ID NO:Shown in 10;For expanding
PAH gene introns 4 arrive the primer of introne 5, forward primer such as SEQ ID NO:Shown in 11, reverse primer such as SEQ ID NO:
Shown in 12;For expanding the primer that PAH gene introns 5 arrive introne 7, forward primer such as SEQ ID NO:Shown in 13, reversely
Primer such as SEQ ID NO:Shown in 14;For expanding the primer that PAH gene introns 5 arrive introne 11, forward primer such as SEQ
ID NO:Shown in 15, reverse primer such as SEQ ID NO:Shown in 16;For expanding PAH gene introns 9 to 3 downstream of exons 1
Outside sequence(It is held positioned at gene 3 ')Primer, forward primer such as SEQ ID NO:Shown in 17, reverse primer such as SEQ ID NO:
Shown in 18, primer SEQ ID NO:1 and primer SEQ ID NO:2 amplified fragments, 1 length is 12594bp, primer SEQ ID NO:3
With primer SEQ ID NO:4 amplified fragments, 2 length is 12764bp, primer SEQ ID NO:5 and primer SEQ ID NO:6 amplifications
3 length of segment is 12067bp, primer SEQ ID NO:7 and primer SEQ ID NO:8 amplified fragments, 4 length is 12890bp, is drawn
Object SEQ ID NO:9 and primer SEQ ID NO:10 amplified fragments, 5 length is 11846bp, primer SEQ ID NO:11 and primer
SEQ ID NO:12 amplified fragments, 6 length is 12027bp, primer SEQ ID NO:13 and primer SEQ ID NO:14 amplified fragments
7 length are 12825bp, primer SEQ ID NO:15 and primer SEQ ID NO:16 amplified fragments, 8 length be 12553bp, primer
SEQ ID NO:17 and primer SEQ ID NO:18 amplified fragments, 9 length is 12764bp, the total coamplification 88171bp's of 9 segments
Genome area covers PAH gene whole extrons(Extron coverage rate 100%)With whole intron sequences(Introne covers
Rate 100%)And 3307bp length sequences on the outside of 3 downstream of exons 1 upstream outer 4145bp length sequences and exons 1.
The present invention also provides a kind of kit for specific PCR augmentation detection PAH gene mutations, comprising above-mentioned
One or more pairs of primers in primer sets can also include one or more of reagent in the kit:Utilize the primer
Carry out the reagent of Long fragment PCR reaction;The reagent D NA that Long fragment PCR reaction is carried out using the primer is gathered preferably wherein
Synthase, buffer solution and dNTP mixtures;For handling amplified production so that amplified production can be used in high throughput sequencing technologies
Reagent, mentioned reagent can be specifically 10 × GeneAmp High Fidelity PCR buffer solutions;10mmol/L dNTP;
5mol/L glycine betaines;DMSO;5U/ μ l polymerase mixtures contain following groups in total volume is the PCR reaction system of 50 μ l
Point:10 × GeneAmp High Fidelity PCR buffer solutions, 5 μ l, 10mmol/LdNTP2 μ l, 10 μm of forward and reverse primers of ol/L
Each 51 μ l, 50ng/ μ l genomic DNAs of μ l, DMSO2.5 μ l, 5U/ μ l polymerase mixtures of 1 μ l, 5mol/L glycine betaine, 2 μ l, water
30.5μl。
The PCR primer group or kit of the present invention has the purposes of detection PAH gene mutations and in phenylalanine hydroxylase
Purposes in enzyme deficiency disease genetic test.
The present invention also provides a kind of methods for vitro detection PAH gene mutations, comprise the following steps:(1)Using
Human gene group DNA is as template, the primer sets formed using 9 pairs of primers of the present invention, under conditions of suitable for amplification purpose nucleic acid,
PAH genes are expanded using LR-PCR technologies;(2)To 9 long segment products of amplification, purifying recycling is carried out;(3)It will be pure
9 PCR products changed are mixed, and are quantified, and obtain the PCR product library of 1 people's genome DNA sample;(4)To
The PCR product library arrived carries out high-throughput sequencing library structure;(5)Obtained multiple sequencing libraries are mixed, according to text
Storehouse type is different, and different microarray datasets is selected to be sequenced;(6)Single sample is sequenced by bioinformatic analysis and is obtained
DNA sequencing fragment compare to reference on PAH genes, carrying out SNVs and Indels extractions, and carry out the analysis of structure variation, arrange
Except polymorphic variation obtains sample P AH gene mutation information.
The method of the detection PAH gene mutations of the present invention, preferably includes following step:(1)Using genomic DNA as mould
Plate is chosen PAH genes and designs 9 pairs of PCR primers, PAH genes expanded using LR-PCR technologies, PCR reaction system bags
Glycine betaine containing 0.5M and 5%DMSO, PCR reaction condition use 2 footwork PCR;(2)To 9 long segment products of amplification, carry out pure
Change recycling, and quantified;(3)9 PCR products of purifying are subjected to equal proportion mixing, and are quantified, obtain 1 people's base
Because of the PCR product library of group DNA sample;(4)For 1 PCR product library, using one step of swivel base enzyme process complete DNA fragmentation,
End is repaired and connector coupled reaction, and Index1 sequence labels and Index2 sequence labels are added at the both ends for interrupting post-fragment,
To build the upper machine sequencing library in each PCR product library;Wherein Index1 sequence labels and Index2 sequence labels is included
Label it is different;The label that different PCR product libraries use is different from each other, to distinguish different genes group DNA sample;To each survey
Preface storehouse carries out quality inspection and quantifies;(5)By multiple sequencing libraries(Label can be distinguished)Mixed in equal amounts is loaded in Flow Cell chips
On, in Illumina gene sequencers(Illumina Miseq sequenators, Illumina NextSeq500 sequenators or
Illumina HiSeq X Ten sequenators)Upper progress both-end is sequenced in synthesis;(6)Different bases is distinguished based on sequence label
It because of a group DNA sample, is split by the sequence label identified in sequence results, it is corresponding to establish each genome DNA sample
Sequencing result data are compared the DNA sequencing fragment that single sample sequencing obtains to reference to PAH bases by bioinformatic analysis
Because upper, progress SNVs and Indels extractions, and the analysis of structure variation is carried out, it excludes polymorphic variation and obtains sample P AH bases
Because of abrupt information.
In the detection method of the present invention, the DNA fragmentation method interrupts method including chemistry and physics interrupts method,
Described in chemical method include traditional enzymatic cleavage methods and new swivel base enzyme process, the physics interrupt method and interrupts method including ultrasound
Or machinery interrupts method, after the DNA is interrupted, obtains the segment of length 400bp-600bp, the method for purifying and recycling include but
It is not limited to magnetic bead recycling or electrophoresis is tapped and recovered.
The present invention detection method in, the sequencing technologies include but not limited to Illumina sequencing technologies or
Other two generations sequencing technologies;Can also be three generations's sequencing technologies, such as PacBio RSII sequenators and PacBio Sequel are surveyed
Sequence instrument;Different banking process is used for different sequenators.
Embodiment 1
Extracting genome DNA:Person under inspection peripheral blood 2ml is gathered, is placed in EDTA anticoagulant tubes, takes EDTA anticoagulation cirumferential blood samples
0.2ml extracts DNA by whole blood DNA extracts kit specification, and DNA concentration is analyzed with Qubit2.0, the genome of extraction
DNA goes to next step pcr template use, this research is altogether detected 5 gene DNA samples, wherein 1 gene DNA sample
For product there are known pathogenic mutation site, 4 are normal human gene group DNA.
Embodiment 2
LR-PCR is expanded:According to PAH gene orders, design 9 pairs of PAH gene-specific primers of synthesis, using GeneAmp High
Fidelity PCR System carry out LR-PCR, and 9 larger sequence fragments of coamplification are respectively 1,2,3,4,5,6,7,8 and 9, draw
Object sequence and amplified production size are as shown in table 1, using GeneAmp High Fidelity PCR System, setting reaction item
Part carries out LR-PCR in Veriti 96-well Thermal Cycler PCR instruments, and PCR reaction total volumes are 50 μ l, including
10 × GeneAmp High Fidelity PCR buffer solutions, 5 μ l, 10mmol/L dNTP, 2 μ l, 10 μm of ol/L are forward and reverse to be drawn
Each 5 2.5 μ l, 5U/ μ L polymerase mixtures of μ l, DMSO, 1 μ l, 50ng/ μ l genomic DNAs of 1 μ l, 5mol/L glycine betaine, 2 μ l of object,
30.5 μ l of water, PCR cycle parameter:98 DEG C of denaturation 1min;98 DEG C of 10sec, 68 DEG C of 13min, totally 30 cycle, last 72 DEG C of extensions
15min, PCR reaction are completed in Veriti 96-well Thermal Cycler PCR instruments.
Table 1 expands the LR-PCR primers of PAH genes:
Note:F is forward primer(Sense primer), R is reverse primer(Anti-sense primer), the PCR primer sequence in table is followed successively by:
SEQ ID NO:1、SEQ ID NO:2、SEQ ID NO:3、SEQ ID NO:4、SEQ ID NO:5、SEQ ID NO:6、SEQ
ID NO:7、SEQ ID NO:8、SEQ ID NO:9、SEQ ID NO:10、SEQ ID NO:11、SEQ ID NO:12、SEQ ID
NO:13、SEQ ID NO:14、SEQ ID NO:15、SEQ ID NO:16、SEQ ID NO:17、SEQ ID NO:18。
After the completion of LR-PCR, 3 μ lPCR products is taken to be detected through 0.6% agarose gel electrophoresis, Fig. 1 shows 9 amplifications
Clip size is consistent with theoretical value, and target stripe is apparent from, and without non-specific amplification, illustrates the LR-PCR reactions of selection
System and condition are suitable.
Embodiment 3
LR-PCR product purifications and quantitative:LR-PCR products are purified by paramagnetic particle method, using 2.0 fluophotometers of Qubit to every
1st ~ No. 9 product after purification of a genome DNA sample carries out DNA concentration and quantifies, 5 genome DNA samples, 45 LR- in total
The Concentration Testing result of pcr amplification product is as follows:
DNA concentration detects(Qubit 2.0)
Since the length scale of 9 amplified fragments is basically identical, 9 PCR products corresponding to same gene group DNA sample are pressed
Etc. quality mixed, and use Agencourt AMPure XP magnetic beads(Beckman Coulter companies of the U.S.)It is concentrated
Enrichment, is quantified with 2.0 fluophotometers of Qubit.
Embodiment 4
Library construction:Library construction uses TruePrepTM DNA Library Prep Kit V2(Chinese Vazyme companies)Into
Prepared by row, concrete operation step is as follows:
1st, the DNA fragmentation of swivel base enzyme process, end reparation and connector coupled reaction:
1)It will be spare after thaw at RT 5 × TTBL solution, the mixing that turns upside down;
2)Following reagent is sequentially added in the PCR pipe that sterilizes:
Reagent | Volume | Final concentration/amount |
Mixing PCR product after purification | 3μl(10ng/µl) | 30ng |
5×TTBL | 10µl | 1× |
TTE Mix V50 | 5µl | - |
ddH2O | 32µl | - |
Total volume | 50µl |
3)Mixed liquor is gently blown and beaten to 20 abundant mixings;
4)Quick centrifuge;
5)PCR pipe is placed in Veriti 96-well Thermal Cycler PCR instruments(American AB I companies)On, it sets as follows
Response procedures:
Heat lid | 105℃ |
55℃ | 10 Min |
10℃ | Hold |
2nd, fragmentation products are purified using Agencourt AMPure XP magnetic beads:
1)50 μ l fragmentation products are transferred in new 1.5mL low adsorption centrifuge tubes, the concussion mixing that is vortexed Agencourt
AMPure XP magnetic beads are simultaneously drawn 50 μ l and are moved in 1.5mL low adsorption centrifuge tubes, gently blown and beaten using pipettor 10 times it is fully mixed
It is even, it is incubated at room temperature 5 minutes;
2)The of short duration centrifugation of low adsorption centrifuge tube is placed in separating magnetic bead and liquid in magnetic frame.Treat that solution is clarified(About 5 minutes)
Carefully remove supernatant;
3)It keeps centrifuge tube always in magnetic frame, adds in the 80% ethyl alcohol rinsing magnetic bead of 200 μ l Fresh, be placed in room temperature
Lower incubation carefully removes supernatant after 30 seconds;
4)Step 3 is repeated, amounts to rinsing twice;
5)Centrifuge tube is kept in magnetic frame, to uncap and be air-dried 10 minutes always;
6)Centrifuge tube from magnetic frame is taken out, adds in the ultrapure water elution of 26 μ l sterilizings, is gently blown and beaten using pipettor fully mixed
It is even, the of short duration centrifugation of centrifuge tube is placed in separating magnetic bead and liquid in magnetic frame, treats that solution is clarified(About 5 minutes)It is careful to draw 24
In the PCR pipe of μ l supernatants extremely.
3rd, PCR enrichments and connection sequence label;
1)Above-mentioned sterilizing PCR pipe is placed in ice bath, adds each reactive component successively:
Reagent | Volume | Final concentration |
The product of previous step | 24µl | - |
5×TAB | 10µl | 1× |
PPM | 5µl | - |
N503*(Tag primer) | 5µl | - |
N705*(Tag primer) | 5µl | - |
TAE | 1µl | - |
Total volume | 50µl |
*, 8 kinds of N5XX and 12 kinds are provided in TruePrepTM Index Kit V2 for Illumina (Vazyme #TD202)
N7XX can voluntarily be selected according to sample size and Index selection strategies;
2)Abundant mixing is gently blown and beaten using pipettor, PCR pipe is placed in PCR instrument and is reacted as follows:
4th, the sorting of amplified production length and purifying;
1)It is vortexed and shakes mixing Agencourt AMPure XP magnetic beads and draw 35 μ l volumes into above-mentioned 50 μ lPCR products, make
10 abundant mixings are gently blown and beaten with pipettor, are incubated at room temperature 5 minutes;
2)The of short duration centrifugation of reaction tube is placed in separating magnetic bead and liquid in 96 hole magnetic frames, treats that solution is clarified(About 5 minutes)It is small
The heart shifts supernatant into new 1.5ml low adsorption centrifuge tubes, abandons magnetic bead;
3)It is vortexed and shakes mixing Agencourt AMPure XP magnetic beads and draw 7.5 μ l volumes into above-mentioned centrifuge tube, use shifting
Liquid device gently blows and beats 10 abundant mixings, is incubated at room temperature 5 minutes;
4)The of short duration centrifugation of reaction tube is placed in separating magnetic bead and liquid in magnetic frame, treats that solution is clarified(About 5 minutes)It is careful to move
Except supernatant;
5)It keeps centrifuge tube always in magnetic frame, adds in the 80% ethyl alcohol rinsing magnetic bead of 200 μ l Fresh, incubation at room temperature
Supernatant is carefully removed after 30 seconds;
6)Step 5 is repeated, amounts to rinsing twice;
7)Centrifuge tube is kept in magnetic frame, to uncap always and be air-dried magnetic bead 10 minutes;
8)Centrifuge tube from magnetic frame is taken out, adds in the ultrapure water elution of 22 μ l sterilizings, is gently blown and beaten using pipettor fully mixed
It is even, the of short duration centrifugation of centrifuge tube is placed in separating magnetic bead and liquid in magnetic frame, treats that solution is clarified(About 5 minutes)It is careful to draw 20
μ l supernatants are into new sterile centrifugation tube, in -20 DEG C of preservations.
5th, sequencing library quality testing;
1)Qubit 2.0 detects DNA concentration;
2)Qualitative and quantitative analysis is carried out to sequencing library with 2200 TapeStation System of Agilent, Fig. 2 is survey
The schematic diagram of preface storehouse analysis result shows fragment size distribution scope, peak position 484bp.
Embodiment 5
Machine is sequenced on Illumina MiSeq sequenators:It is carried out according to the S.O.P. of Illumina MiSeq sequenators
After the setting of the relevant parameters such as 2x300PE, Index, instrument carries out DNA fasciations on sequencing Flow Cell chips into, side automatically
Side sequencing is synthesized, specific sequencing library is loaded on Flow Cell chips, joint sequence and the Flow Cell cores at library both ends
Oligonucleotide sequence in piece substrate is complementary, fixed all to form a cluster through bridge type PCR amplification per bar segment, and when sequencing adopts
Side sequencing reaction is synthesized with reversible distal edge, i.e., during base extension, each circular response can only extend one just
Really complementary base confirms base species according to different fluorescence signals, after hundreds of Xun Huans, reads nucleotide sequence.
Embodiment 6
Interpretation of result:Sequencing result is that a series of DNA read sequence(reads), passed through using MiSeq Reporter (MSR) software
It identifies the sequence label in sequence results, establishes the data that each label corresponds to genome DNA sample sequencing result, filter off simultaneously
Except joint sequence and low quality data, it will be sequenced by BWA (Burrows-Wheeler Aligner) and read sequence comparison to reference to sequence
On row, SNVs and Indels is carried out using GATK and is extracted, and carry out structure variation analysis, the sample is obtained after excluding polymorphic variation
Product PAH gene mutation information, to the BAM file application Integrative Genomics Viewer of acquisition(IGV) software carries out
The visual analyzing for reading sequence is compared, Fig. 3 is the overburden depth and coverage rate schematic diagram of PAH gene Illumina MiSeq sequencings,
In the detection range of PAH genes 88kb most of region sequencing depth up to 1000 × more than, minimum sequencing depth 96 ×, own
The coverage rate of extron and all intrones is 100%, illustrates that this method can realize all standing sequencing of PAH genes, Fig. 4 is
The IGV views of two PAH pathogenic mutations, display PAH genes are c.1223G>A is mutated and is c.116_118delTCT mutated, and judging should
C.1223G the PAH genotype of genome DNA sample is>A/c.116_118delTCT, the testing result are sequenced using Sanger
Verification, as a result unanimously.
Finally it should be noted that:The foregoing is only a preferred embodiment of the present invention, is not intended to limit the invention,
Although the present invention is described in detail with reference to the foregoing embodiments, for those skilled in the art, still may be used
To modify to the technical solution recorded in foregoing embodiments or carry out equivalent substitution to which part technical characteristic,
Within the spirit and principles of the invention, any modifications, equivalent replacements and improvements are made should be included in the present invention's
Within protection domain.
Sequence table
<110>Nanjing Women and Children Healthcare Hospital
<120>A kind of amplimer, kit and its detection method for detecting PAH gene mutations
<160> 18
<170> SIPOSequenceListing 1.0
<210> 1
<211> 31
<212> DNA
<213>Artificial sequence ()
<400> 1
ggtattacct ggactgtggg accatgttga a 31
<210> 2
<211> 25
<212> DNA
<213>Artificial sequence ()
<400> 2
ctcggctgtg acagtcgctc agaca 25
<210> 3
<211> 29
<212> DNA
<213>Artificial sequence ()
<400> 3
ggtttcctca gccagattcc ttccgagta 29
<210> 4
<211> 31
<212> DNA
<213>Artificial sequence ()
<400> 4
gagagcacag caaatccaag aaccgagaat g 31
<210> 5
<211> 31
<212> DNA
<213>Artificial sequence ()
<400> 5
attcctggta acttctctgc ctggtgtctt c 31
<210> 6
<211> 27
<212> DNA
<213>Artificial sequence ()
<400> 6
cttgaacctg ctgtcagact cgcctct 27
<210> 7
<211> 32
<212> DNA
<213>Artificial sequence ()
<400> 7
aaagtacaga gagttcccag gtctttcatc cc 32
<210> 8
<211> 27
<212> DNA
<213>Artificial sequence ()
<400> 8
cttcccgcct tgtcacctac actcctc 27
<210> 9
<211> 32
<212> DNA
<213>Artificial sequence ()
<400> 9
aggagataag acacttgcca gttacacaac ga 32
<210> 10
<211> 31
<212> DNA
<213>Artificial sequence ()
<400> 10
cccttctctc ttccttcaca tccagcaatc a 31
<210> 11
<211> 27
<212> DNA
<213>Artificial sequence ()
<400> 11
gcctccctaa agccttcctc ctgtctc 27
<210> 12
<211> 30
<212> DNA
<213>Artificial sequence ()
<400> 12
gcagcactat tcacgatagc acagacatgg 30
<210> 13
<211> 34
<212> DNA
<213>Artificial sequence ()
<400> 13
gattaactaa ctgatgtgcc gaaggtcatg tagc 34
<210> 14
<211> 29
<212> DNA
<213>Artificial sequence ()
<400> 14
cagtgctgct cttctgttag tctggaggt 29
<210> 15
<211> 28
<212> DNA
<213>Artificial sequence ()
<400> 15
ctgctaacct aacctgcgtt ctgctgtg 28
<210> 16
<211> 33
<212> DNA
<213>Artificial sequence ()
<400> 16
atgttccatg cctgtcatcc atcactgata aga 33
<210> 17
<211> 28
<212> DNA
<213>Artificial sequence ()
<400> 17
tagccacatt gcctgtcctg gaagttga 28
<210> 18
<211> 30
<212> DNA
<213>Artificial sequence ()
<400> 18
gggatcacca gagcagtctc ctgaaagatg 30
Claims (6)
1. a kind of amplimer, kit and its detection method for detecting PAH gene mutations, which is characterized in that special for PCR
Property augmentation detection PAH gene mutations primer sets, totally 9 pairs of this group of PCR primer, respectively it is as follows:
For expanding 1 upstream outer sequence of PAH gene extrons(Positioned at gene 5 ' end)To the primer of introne 2, forward direction is drawn
Object such as SEQ ID NO:Shown in 1, reverse primer such as SEQ ID NO:Shown in 2;
For expanding 2 upstream of PAH gene introns(5 ' ends)To 2 downstream of introne(3 ' ends)Primer, forward primer such as SEQ
ID NO:Shown in 3, reverse primer such as SEQ ID NO:Shown in 4;
For expanding the primer that PAH gene introns 2 arrive introne 3, forward primer such as SEQ ID NO:Shown in 5, reversely draw
Object such as SEQ ID NO:Shown in 6;
For expanding 3 upstream of PAH gene introns(Introne 5 ' is held)To introne 3 downstream(Introne 3 ' end)Primer,
Forward primer such as SEQ ID NO:Shown in 7, reverse primer such as SEQ ID NO:Shown in 8;
For expanding the primer that PAH gene introns 3 arrive introne 4, forward primer such as SEQ ID NO:Shown in 9, reversely draw
Object such as SEQ ID NO:Shown in 10;
For expanding the primer that PAH gene introns 4 arrive introne 5, forward primer such as SEQ ID NO:Shown in 11, reversely draw
Object such as SEQ ID NO:Shown in 12;
For expanding the primer that PAH gene introns 5 arrive introne 7, forward primer such as SEQ ID NO:Shown in 13, reversely draw
Object such as SEQ ID NO:Shown in 14;
For expanding the primer that PAH gene introns 5 arrive introne 11, forward primer such as SEQ ID NO:Shown in 15, reversely
Primer such as SEQ ID NO:Shown in 16;
For expanding PAH gene introns 9 to sequence on the outside of 3 downstream of exons 1(It is held positioned at gene 3 ')Primer, forward direction draws
Object such as SEQ ID NO:Shown in 17, reverse primer such as SEQ ID NO:Shown in 18;
For the kit of PCR specific amplifications detection PAH gene mutations, one or more pairs of primers in primer sets are included.
2. a kind of amplimer, kit and its detection method for detecting PAH gene mutations according to claim 1,
It is characterized in that:The kit for the detection PAH gene mutations of PCR specific amplifications is also comprising one or more reagents, profit
Long-chain PCR " the reagents of long-range PCR, LR-PCR " reactions are carried out with the primer;Long segment is carried out using the primer
Reagent D NA polymerases, buffer solution and the dNTP mixtures of PCR reactions;For handling amplified production so that amplified production can be used
Reagent in high throughput sequencing technologies.
3. a kind of amplimer, kit and its detection method for detecting PAH gene mutations according to claim 2,
It is characterized in that:The kit includes following reagents, one or more pairs of primers, 10 × GeneAmp High in PCR primer group
Fidelity PCR buffer solutions, 10mmol/LdNTP, 5mol/L glycine betaine, DMSO and 5U/ μ L polymerase mixtures.
4. a kind of amplimer, kit and its detection method for detecting PAH gene mutations according to claim 3,
It is characterized in that:Contain following components in the PCR reaction systems for being 50 μ l in total volume:Each 1 μ l of each PCR primer, primer it is dense
It spends for 10 μm of ol/L;10 × GeneAmp High Fidelity PCR buffer solutions 5 μ l, 10mmol/L, dNTP2 μ l, 10 μm of ol/L
Forward and reverse each 5 μ l, DMSO2.5 μ l, 5U/ μ l polymerase mixtures of 1 μ l, 5mol/L glycine betaine, 1 μ l, 50ng/ μ l genomes of primer
DNA2 μ l, 30.5 μ l of water.
5. amplimer, kit and its detection method of a kind of detection PAH gene mutations according to claim 1-4,
Comprise the following steps:
(1)Using human gene group DNA as template, the primer sets of usage right requirement 1, in the condition suitable for amplification purpose nucleic acid
Under, PAH genes are expanded using LR-PCR technologies, wherein being made of per pair of primers forward primer and reverse primer;
(2)To 9 long segment products of amplification, purifying recycling is carried out;
(3)9 PCR products of purifying are mixed, and are quantified, obtain the PCR product of 1 people's genome DNA sample
Library;
(4)DNA fragmentation processing is carried out to obtaining PCR product library;Wherein described DNA fragmentation method includes the chemistry side of interrupting
Method and physics interrupt method, wherein the chemical method includes swivel base enzyme process and traditional enzymatic cleavage methods, the physical method includes
Ultrasound interrupts method or machinery interrupts method, and the PCR product library interrupted is built 1 sequencing text using splice tag technology
Storehouse, can be respective to distinguish by adding different library connector Barcode Adapter to different genome DNA samples
Sequencing library also can handle PCR product library without fragmentation, directly build single SMRTBell libraries;
(5)Obtained multiple sequencing libraries are mixed, it is different to be sequenced type according to library, select different microarray datasets into
Row sequencing is read long sequencing etc. including the sequencing of Illumina both-ends, the sequencing of Ion Torrent semiconductors and PacBio SMRT long, is obtained
Obtain the sequencing data in PCR product library;
(6)Different genome DNA sample is distinguished based on label B arcode sequences, by bioinformatic analysis by single sample
The DNA sequencing fragment that product sequencing obtains is compared onto reference PAH genes, is carried out SNVs and Indels extractions, and is carried out structural
The analysis of variation excludes the PAH gene mutation information that polymorphic variation obtains the DNA sample.
6. a kind of amplimer, kit and its detection method for detecting PAH gene mutations according to claim 5,
It is characterized in that:Using human gene group DNA as template, choose PAH genes and design 9 pairs of PCR primers, using LR-PCR technologies pair
PAH genes are expanded, and the region of amplification includes PAH gene whole extrons and whole intron sequences and part of exon 1
Sequence on the outside of 3 downstream of upstream outer sequence and exons 1, exons 1 upstream outer sequence are located at gene 5 ' end, under exons 13
Trip outside sequence is located at the end of gene 3 ', and in addition each amplified fragments have overlay region with adjacent amplified fragments, are spelled available for segment
It connects and haplotype reconstruction, and available for big structure variation is detected, refers mainly to deletion mutant and Duplication mutation;
To 9 long segment products of amplification, purifying recycling is carried out, 9 PCR products of purifying are mixed, and is quantified,
1 PCR product library by inspection DNA sample is obtained, corresponding 1 by inspection genome DNA sample;
To obtained PCR product library construction sequencing library, partly led including Illumina both-ends sequencing library, Ion Torrent
Body sequencing library and SMRTBell libraries, are sequenced in corresponding microarray dataset, after obtaining sequencing data, carry out biological letter
Credit analysis is ceased, obtains PAH full length genes variation information.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810154162.9A CN108060227B (en) | 2018-02-22 | 2018-02-22 | Amplification primer, kit and detection method for detecting PAH gene mutation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810154162.9A CN108060227B (en) | 2018-02-22 | 2018-02-22 | Amplification primer, kit and detection method for detecting PAH gene mutation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108060227A true CN108060227A (en) | 2018-05-22 |
CN108060227B CN108060227B (en) | 2022-03-08 |
Family
ID=62134532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810154162.9A Active CN108060227B (en) | 2018-02-22 | 2018-02-22 | Amplification primer, kit and detection method for detecting PAH gene mutation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108060227B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111286533A (en) * | 2019-06-27 | 2020-06-16 | 北京嘉宝仁和医疗科技有限公司 | Multiplex PCR primer and application |
CN111378653A (en) * | 2018-12-29 | 2020-07-07 | 北京希望组生物科技有限公司 | Primer, kit and method for detecting SCA gene mutation |
CN111524552A (en) * | 2020-04-24 | 2020-08-11 | 深圳市儒翰基因科技有限公司 | Simplified genome sequencing library construction and analysis method, detection equipment and storage medium |
CN113186265A (en) * | 2021-02-19 | 2021-07-30 | 苏州大学附属第二医院 | Long-range PCR method and kit for detecting polymorphism variation of CYP2D6 gene |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104232761A (en) * | 2014-08-27 | 2014-12-24 | 武汉凯吉盈科技有限公司 | Gene complete segment quick sequencing method |
CN104789664A (en) * | 2015-04-02 | 2015-07-22 | 安诺优达基因科技(北京)有限公司 | Primer set, method and kit for Long-range PCR (polymerase chain reaction) detection of BRCA (breast cancer susceptibility gene) 1 and BRCA 2 |
CN104975081A (en) * | 2015-06-01 | 2015-10-14 | 南京市妇幼保健院 | Amplimers, kit and method for detecting PKD1 gene mutation |
CN105886605A (en) * | 2015-03-05 | 2016-08-24 | 南京市妇幼保健院 | Amplification primer for detecting PKD2 gene mutation and detection method |
US20160281166A1 (en) * | 2015-03-23 | 2016-09-29 | Parabase Genomics, Inc. | Methods and systems for screening diseases in subjects |
CN106544431A (en) * | 2016-10-28 | 2017-03-29 | 林巍 | The sequencing library construction method of hyperphenylalaninemia related gene exons mutation |
-
2018
- 2018-02-22 CN CN201810154162.9A patent/CN108060227B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104232761A (en) * | 2014-08-27 | 2014-12-24 | 武汉凯吉盈科技有限公司 | Gene complete segment quick sequencing method |
CN105886605A (en) * | 2015-03-05 | 2016-08-24 | 南京市妇幼保健院 | Amplification primer for detecting PKD2 gene mutation and detection method |
US20160281166A1 (en) * | 2015-03-23 | 2016-09-29 | Parabase Genomics, Inc. | Methods and systems for screening diseases in subjects |
CN104789664A (en) * | 2015-04-02 | 2015-07-22 | 安诺优达基因科技(北京)有限公司 | Primer set, method and kit for Long-range PCR (polymerase chain reaction) detection of BRCA (breast cancer susceptibility gene) 1 and BRCA 2 |
CN104975081A (en) * | 2015-06-01 | 2015-10-14 | 南京市妇幼保健院 | Amplimers, kit and method for detecting PKD1 gene mutation |
CN106544431A (en) * | 2016-10-28 | 2017-03-29 | 林巍 | The sequencing library construction method of hyperphenylalaninemia related gene exons mutation |
Non-Patent Citations (5)
Title |
---|
HAIYING JIA等: "Long-range PCR in next-generation sequencing: comparison of six enzymes and evaluation on the MiSeq sequencer", 《COMPARATIVE STUDY》 * |
J ZSCHOCKE等: "Large heterozygous deletion masquerading as homozygous missense mutation: a pitfall in diagnostic mutation analysis", 《CASE REPORTS》 * |
JAMES A. CASBON等: "Reflex: intramolecular barcoding of long-range PCR products for sequencing multiple pooled DNAs", 《NUCLEIC ACIDS RES. 》 * |
LOURDES R.DESVIAT等: "Identification of exonic deletions in the PAH gene causing phenylketonuria by MLPA analysis", 《CLINICA CHIMICA ACTA》 * |
YONG WHA LEE等: "Mutation analysis of PAH gene and characterization of a recurrent deletion mutation in Korean patients with phenylketonuria", 《EXP MOL MED.》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111378653A (en) * | 2018-12-29 | 2020-07-07 | 北京希望组生物科技有限公司 | Primer, kit and method for detecting SCA gene mutation |
CN111286533A (en) * | 2019-06-27 | 2020-06-16 | 北京嘉宝仁和医疗科技有限公司 | Multiplex PCR primer and application |
CN111286533B (en) * | 2019-06-27 | 2023-04-28 | 北京嘉宝仁和医疗科技股份有限公司 | PAH gene multiplex PCR primer and application thereof |
CN111524552A (en) * | 2020-04-24 | 2020-08-11 | 深圳市儒翰基因科技有限公司 | Simplified genome sequencing library construction and analysis method, detection equipment and storage medium |
CN111524552B (en) * | 2020-04-24 | 2021-05-11 | 深圳市儒翰基因科技有限公司 | Simplified genome sequencing library construction and analysis method, detection equipment and storage medium |
CN113186265A (en) * | 2021-02-19 | 2021-07-30 | 苏州大学附属第二医院 | Long-range PCR method and kit for detecting polymorphism variation of CYP2D6 gene |
Also Published As
Publication number | Publication date |
---|---|
CN108060227B (en) | 2022-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3656875B1 (en) | Non-invasive prenatal diagnosis | |
CN104975081B (en) | Detect amplimer, kit and its detection method of PKD1 gene mutation | |
CN104531883B (en) | The detection kit and detection method of PKD1 gene mutations | |
CN108138227A (en) | Inhibit error in DNA fragmentation is sequenced using the redundancy read that (UMI) is indexed with unique molecular | |
CN107849607A (en) | The single-molecule sequencing of plasma dna | |
CN105648045B (en) | The method and apparatus for determining fetus target area haplotype | |
HUE030510T2 (en) | Diagnosing fetal chromosomal aneuploidy using genomic sequencing | |
CN105555970B (en) | Method and system for simultaneous haplotyping and chromosomal aneuploidy detection | |
CN108060227A (en) | A kind of amplimer, kit and its detection method for detecting PAH gene mutations | |
CN111073961A (en) | High-throughput detection method for gene rare mutation | |
CN107475403A (en) | The analysis method of the method for detection Circulating tumor DNA, kit and its sequencing result from peripheral blood dissociative DNA | |
CN106011302A (en) | ATP7B (ATPase Cu2+transporting beta polypeptide) gene mutation detection primer set and kit, ATP7B gene mutation detection method and uses of ATP7B gene mutation detection primer kit | |
CN106995851A (en) | Expand PCR primer, the kit of detection PKD1 gene mutations and the application of PKD1 extron overlength fragments | |
CN110592185A (en) | Method for designing hypercholesteremia virulence gene screening probe and gene chip thereof | |
KR102559124B1 (en) | Composition for amplifying FLT3 gene and Uses thereof | |
CN113308527A (en) | Gene composition, chip and kit for screening refractory hereditary bone diseases | |
CN112662754A (en) | Application method of composition for predicting probability of occurrence of small ear deformity | |
CN110438219A (en) | Primer, probe, kit and method based on the noninvasive pre-natal diagnosis Pasteur oedema tire of droplet type digital pcr | |
CN103509801A (en) | Skeletal muscle chloride ion channel gene mutant and its application | |
CN113265409B (en) | TIMM21 mutant gene, primer, kit and method for detecting same and application thereof | |
CN113981059B (en) | Primer composition for detecting thalassemia mutant gene and reagent thereof | |
RU2717023C1 (en) | Method for determining foetal karyotype of pregnant woman based on sequencing hybrid readings consisting of short fragments of extracellular dna | |
WO2024076469A1 (en) | Non-invasive methods of assessing transplant rejection in pregnant transplant recipients | |
WO2020226528A1 (en) | Method for determining fetal karyotype in a pregnant woman | |
CN117106805A (en) | TOMM5 mutant gene, primer, kit and method for detecting same and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |